COVID-19 Vaccines 101: FAQ
Paul Offit, MD, director, Vaccine Education Center, and professor of pediatrics, Children’s Hospital of Philadelphia; professor of vaccinology, Perelman School of Medicine, University of Pennsylvania.
CDC: “Vaccines: The Basics,” “When the vaccine is limited, who gets the vaccine first?” “Understanding How COVID-19 Vaccines Work”, “Advisory Committee on Immunization Practices (ACIP) Meeting, November 23,” “Understanding COVID-19 mRNA Vaccines”.
JAMA: “COVID-19 and mRNA vaccines – First major test for a new approach.”
The Lancet: “Efficacy of the Oxford-AstraZeneca COVID-19 vaccine”.
Facebook interview: Mark Zuckerberg and Anthony Fauci, MD, November 30, 2020.
FDA: “Vaccines and Related Biologics Advisory Committee Meeting, December 17, 2020”.
Naor Bar-Zeev, PhD, Associate Professor of International Health and Vaccinology and Deputy Director, International Vaccine Access Center, Johns Hopkins Bloomberg School of Public Health, Baltimore.
Statista.com: “The cost per injection of candidates for the Covid-19 vaccine”.
AstraZeneca: “The COVID-19 AZD1222 vaccine is better tolerated in older adults than in young adults with similar immune responses in all age groups.”
The Lancet: “Safety and Immunogenicity of ChAdOx1nCoV-19 in a First-Aid Regimen in Young and Old Adults (COV002) in a Phase 2/3 Randomized Single-Blind Controlled Trial”.
Moderna: “Moderna’s COVID-19 vaccine candidate meets primary efficacy endpoint in first interim analysis of COVE Phase 3 study.”
BMJ.com: “Covid-19: Moderna vaccine is nearly 95% effective, according to trial involving elderly and high-risk people.”
CBS News: “UK warns against giving Pfizer vaccine to people prone to severe allergic reactions.”
Our sincere thanks to